Sisram Medical Ltd (HKG:1696)

Sisram Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	356.4	359.29	354.48	294.29	162.1	173.52
Revenue Growth (YoY)	1.37%	1.36%	20.45%	81.56%	-6.58%	12.73%
Cost of Revenue	136.86	139.77	152.25	127.43	71.79	77.65
Gross Profit	219.54	219.53	202.23	166.86	90.3	95.87
Selling, General & Admin	165.08	159.44	128.76	100.71	58.96	58.78
Research & Development	16.94	18.03	18.02	15.59	10.96	10.47
Other Operating Expenses	5.95	4.03	10.04	7.8	3.78	2.9
Operating Expenses	187.97	181.5	156.82	124.1	73.7	72.15
Operating Income	31.57	38.03	45.41	42.76	16.6	23.73
Interest Expense	-2.36	-2.06	-1.74	-2.01	-1.06	-0.73
Interest & Investment Income	0.65	0.6	0.61	0.54	0.77	1.83
Earnings From Equity Investments	-0.22	-0.42	-0.52	-0.31	-	-
Currency Exchange Gain (Loss)	0.55	0.55	-	0.49	-	0.57
Other Non Operating Income (Expenses)	0.93	0.44	0.48	0.19	0.01	-
EBT Excluding Unusual Items	31.12	37.13	44.24	41.67	16.32	25.39
Other Unusual Items	-	-	-	-	0.34	-0.55
Pretax Income	31.12	37.13	44.24	41.67	16.66	24.84
Income Tax Expense	3.8	4.23	4.16	9.15	1.98	2.9
Earnings From Continuing Operations	27.32	32.9	40.08	32.52	14.68	21.94
Minority Interest in Earnings	-3.77	-1.4	0.09	-1.28	-1.34	-1.15
Net Income	23.55	31.5	40.17	31.25	13.34	20.79
Net Income to Common	23.55	31.5	40.17	31.25	13.34	20.79
Net Income Growth	-38.74%	-21.59%	28.56%	134.15%	-35.80%	-4.79%
Shares Outstanding (Basic)	468	467	466	453	442	442
Shares Outstanding (Diluted)	468	468	467	453	442	442
Shares Change (YoY)	-0.02%	0.34%	3.07%	2.42%	-	-
EPS (Basic)	0.05	0.07	0.09	0.07	0.03	0.05
EPS (Diluted)	0.05	0.07	0.09	0.07	0.03	0.05
EPS Growth	-38.76%	-21.84%	24.78%	128.63%	-35.80%	-4.79%
Free Cash Flow	33.28	35.37	17.29	29.41	16.46	17.87
Free Cash Flow Per Share	0.07	0.08	0.04	0.06	0.04	0.04
Dividend Per Share	0.020	0.020	0.022	0.020	0.009	0.014
Dividend Growth	-8.84%	-8.84%	10.20%	123.02%	-36.07%	10.60%
Gross Margin	61.60%	61.10%	57.05%	56.70%	55.71%	55.25%
Operating Margin	8.86%	10.58%	12.81%	14.53%	10.24%	13.67%
Profit Margin	6.61%	8.77%	11.33%	10.62%	8.23%	11.98%
Free Cash Flow Margin	9.34%	9.84%	4.88%	9.99%	10.16%	10.30%
EBITDA	42.68	47.5	53.99	51.58	23.8	30.37
EBITDA Margin	11.98%	13.22%	15.23%	17.53%	14.68%	17.50%
D&A For EBITDA	11.12	9.47	8.59	8.82	7.2	6.65
EBIT	31.57	38.03	45.41	42.76	16.6	23.73
EBIT Margin	8.86%	10.58%	12.81%	14.53%	10.24%	13.67%
Effective Tax Rate	12.22%	11.40%	9.41%	21.96%	11.90%	11.69%

Source: S&P Capital IQ. Standard template. Financial Sources.